fully agree, yes hard to compare and run a trial with a high competitive endpoint, with the SOC improving the way it appears to be. Curious of the actual comparative %. I topped up again today and staying long term. Covid cases are still climbing rapidly worldwide and now with a UK/EU more contagious variant unfortunately it's spread is outpacing vaccine rollouts. MSB has the products to assist the treatment of some of its long term effects. Other Improvements in Heart, Lung, Back, Graft vers host etc, it might take a few side steps along the way, but we know what the technology can provide. All IMO DYOR.
fully agree, yes hard to compare and run a trial with a high...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.005(0.45%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.15 | $1.11 | $5.667M | 5.064M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 94111 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 70945 | 3 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.005 ( 1.73 %) |
||||
| Open | High | Low | Volume | ||
| $1.11 | $1.15 | $1.11 | 871975 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| MSB (ASX) Chart |